or
forgot password

    • cancer clinical trials in alhambra, CA

    • Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Breast Cancer
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Central Hematology Oncology Medical Group Inc.
    Alhambra, California 91801
    Myeloid Leukemia, Chronic, Chronic-Phase
    Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Colorectal Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Central Hem/Onc Medical Group
    Alhambra, California 91801
    Non-Small Cell Lung Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Breast Cancer
    Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
    Central Hematology Oncology Medical Group, Incorporated - Alhambra
    Alhambra, California 91801
    Breast Cancer
    Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Esophageal Cancer, Gastric Cancer
    Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
    Central Hematology Oncology Medical Group
    Alhambra, California 91801
    Relapsed or Refractory Multiple Myeloma
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10113 Boehringer Ingelheim Investigational Site
    Alhambra, California
    Breast Neoplasms
    Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Acinar Cell Carcinoma of Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Pancreatic Carcinoma Recurrent, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Pancreatic Carcinoma Stage III
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    Central Hematology Oncology Medical Group
    Alhambra, California 91801
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Pancreatic Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Colorectal Cancer
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    Central Hem/Onc Medical Group, Inc.
    Alhambra, California 91801
    Metastatic Colorectal Cancer, Colorectal Cancer
    Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
    Call for Information (Investigational Site 0238)
    Alhambra, California 91801
    Genital Warts, Anal Cancer, Anal Intraepithelial Neoplasia
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    Central Hematology Oncology Medical Group Inc
    Alhambra, California 91801
    Prostate Cancer
    Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Prostate Cancer
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    Central Hematology Oncology Medical Group Inc.
    Alhambra, California 91801
    Carcinoma, Non-Small-Cell Lung
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Central Hematology Oncology Medical Group, Inc
    Alhambra, California 91801
    Non-Hodgkin's Lymphoma
    Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
    Eddie Hu
    Alhambra, California 91801
    Acute Myeloid Leukemia, AML
    Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Ovarian Cancer, Endometrial Cancer
    Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung
    Central Hematology Oncology Medical Group, Inc
    Alhambra, California 91801
    Adenocarcinoma of the Lung
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    Central Hematology Oncology Medical Group, Inc.
    Alhambra, California 91801
    Myelodysplastic Syndrome (MDS)
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    Central Hematology Oncology Medical Group
    Alhambra, California 91801
    Non-small Cell Lung Cancer
    A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
    Central Hematology Oncology Medical Group
    Alhambra, California 91801
    Non-Small Cell Lung Cancer
    Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
    HealthCare Partners
    Alhambra, California 91801
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer